Previously Funded Researchers

Samuel Rowbotham, PhD

Massachusetts General Hospital

Harnessing Genetics and Epigenetics to Combat Pulmonary Hypoplasia

Sameek Roychowdhury, Ph.D., M.D.

The Ohio State University

Identifying Gene Mutations in Lung Cancer That Can Be Attacked With Smart Drugs

Mohsan Saeed, PhD

Trustees of Boston University

Deciphering the Determinants of Coronaviral Tissue Tropism

Hersh Sagreiya, MD

Perelman School of Medicine, University of Pennsylvania

Automated Lung Ultrasound Using an Unsupervised Machine Learning Technique

Ian Saldanha, PhD, MPH, MBBS

Johns Hopkins Bloomberg School of Public Health

Weight Loss Drugs and Asthma: Evidence Synthesis to Inform a Randomized Trial

Amali Samarasinghe, PhD

The University of Tennessee Health Science Center

Influenza Virus Promotes Eosinophil Appetite for Bacteria

Amali Samarasinghe, PhD

The University of Tennessee Health Science Center

Can Eosinophils Help Immune System Defend Against SARS-CoV-2?

Lobelia Samavati, M.D.

Wayne State University

How Immune System Works Differently in Sarcoidosis

Robert M. Samstein, MD, PhD

Mount Sinai

Improving Responses to Immune Checkpoint Inhibitors in Lung Cancer

Amy Sawyer, Ph.D.

The Pennsylvania State University

Treating Claustrophobia in Sleep Apnea Patients Using Positive Airway Pressure

Christopher Schafer, PhD

Oklahoma Medical Research Foundation

Determining How Lung’s Blood Vessels Malfunction in Inflammatory Diseases

John Schoggins, Ph.D.

UT Southwestern Medical Center

New Avenue for Keeping Influenza in Check

Andreas Schwingshackl, MD, PhD

University of California, Los Angeles

TREK-1 potassium channels protect from ventilator-induced lung injury

Stephen Schworer, MD, PhD

The University of North Carolina at Chapel Hill

Mucus Plugging and Regional Heterogeneity in Asthmatic Small Airways

Jessica Seeliger, Ph.D.

State University of New York, Stony Brook

Targeting Latent and Multi-Drug Resistant TB

Leopoldo Nicolas Segal, MD

New York University School of Medicine

Recognizing Treatable Traits Among Critically Ill COVID-19 Patients

Shiladitya Sengupta, PhD

Brigham and Women's Hospital, Inc.

Targeting a Novel Mechanism of Immuno-evasion in Lung Cancer

Shiladitya Sengupta, Ph.D.

Brigham and Women's Hospital, Inc.

Using Nanotechnology to Target Lung Cancer

Lecia V. Sequist, M.D., MPH

Associate Professor, Medicine, Harvard Medical School and Attending Physician, Medicine

Massachusetts General Hospital

Lung Cancer Interception Translational Research Team: Blood-based Early Interception of Lung Cancer

Brittany Sexton, Ph.D.

Massachusetts General Hospital

Discovering Inner Workings of Enzyme Could Lead to Lung Cancer Treatment

David Shackelford, Ph.D.

University of California, Los Angeles

Selectively Targeting Metabolic Needs Unique to Lung Cancer

David Brian Shackelford, PhD

University of California, Los Angeles

Testing Novel Compound to Treat KRAS/LKB1 Mutant Lung Tumors

Lokesh Sharma, PhD

Yale University

Mechanisms of Paradoxical Anti-inflammatory Effects of Type I Interferons in the Lung

Mohammed Shatat, M.D.

Case Western Reserve University

Molecule Could Play Role in Improving Treatment of PAH

David Shechter, Ph.D.

Albert Einstein College of Medicine, Inc.

When the Writing Goes Wrong: Protein Arginine Methyltransferases in Lung Cancer

Abdul Sheikh, Ph.D.

Yale University

Abnormal Lung Blood Vessel Muscle Formation and Pulmonary Hypertension

Jinjun Shi, Ph.D.

Brigham and Women's Hospital, Inc.

Making Lung Cancer Responsive to Treatment for Other Cancers

Megumi Shigematsu, PhD

Thomas Jefferson University

Hidden Short RNAs as Novel Inflammatory Mediators in Asthma

Sunny Shin, Ph.D.

University of Pennsylvania

How Immune Cells Clear Legionnaire's Disease Bacteria from Lungs

Hideki Shishido, Ph.D.

Oregon Health and Science University

Developing New Method to Study Cystic Fibrosis Protein